Wait so the shareholder salvation isn’t that Bioamber still holds the patents after the documented liquidation and assignment of said patents, its that Mitsui does? When that is disproven, how will you go back (and we know with certainty you will)?
Truth is Mitsui sold its interest in the company for a dollar because it was afraid of the liability and ongoing funding requirements. It also took a security against the IP because it continued to be worried about the company meetings it’s obligations. Then the company threw its hands up, unable to meet its obligations, to get protection from the courts. And Mitsui had to settle for pennies on the dollar. All completely consistent with the trajectory of a company going bankrupt and getting liquidated.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.